MCID: SCK001
MIFTS: 36

Sick Building Syndrome malady

Category: Respiratory diseases

Aliases & Classifications for Sick Building Syndrome

About this section

Aliases & Descriptions for Sick Building Syndrome:

Name: Sick Building Syndrome 10 12 36 2 65

Classifications:



External Ids:

Disease Ontology10 DOID:2710
SNOMED-CT59 19076009
MeSH36 D018877
UMLS65 C0037050

Summaries for Sick Building Syndrome

About this section
CDC:2 Indoor environmental quality (IEQ) refers to the quality of a building’s environment in relation to the health and wellbeing of those who occupy space within it. IEQ is determined by many factors, including lighting, air quality, and damp conditions. Workers are often concerned that they have symptoms or health conditions from exposures to contaminants in the buildings where they work. One reason for this concern is that their symptoms often get better when they are not in the building. While research has shown that some respiratory symptoms and illnesses can be associated with damp buildings, it is still unclear what measurements of indoor contaminants show that workers are at risk for disease. In most instances where a worker and his or her physician suspect that the building environment is causing a specific health condition, the information available from medical tests and tests of the environment is not sufficient to establish which contaminants are responsible. Despite uncertainty about what to measure and how to interpret what is measured, research shows that building-related symptoms are associated with building characteristics, including dampness, cleanliness, and ventilation characteristics.

MalaCards based summary: Sick Building Syndrome is related to asthma and oliver-mcfarlane syndrome. An important gene associated with Sick Building Syndrome is PNPLA6 (Patatin Like Phospholipase Domain Containing 6), and among its related pathways are Adipocytokine signaling pathway and Development_Leptin signaling via JAK/STAT and MAPK cascades. Affiliated tissues include testes, eye and bone, and related mouse phenotypes are tumorigenesis and renal/urinary system.

Disease Ontology:10 An extrinsic allergic alveolitis that is characterized by a set of symptoms such as headache, fatigue, eye irritation, and breathing difficulties that affect workers in modern airtight office buildings. The disease is caused by indoor pollutants (as formaldehyde fumes, particulate matter, or microorganisms), and the symptoms tend to disappear when affected individuals leave the building.

Wikipedia:68 Sick building syndrome (SBS) is used to describe situations in which building occupants experience acute... more...

Related Diseases for Sick Building Syndrome

About this section

Graphical network of the top 20 diseases related to Sick Building Syndrome:



Diseases related to sick building syndrome

Symptoms for Sick Building Syndrome

About this section

Drugs & Therapeutics for Sick Building Syndrome

About this section

Drugs for Sick Building Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 15)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Dexamethasoneapproved, investigationalPhase 1190950-02-25743
Synonyms:
(3H)-Dexamethasone
.delta.(sup 1)-9-.alpha.-Fluoro-16-.alpha.-methylcortisol
.gamma.corten
1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone
1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone
1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone
1-Dehydro-16α-methyl-9α-fluorohydrocortisone
137098-19-2
16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol
16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone
16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone
16-alpha-Methyl-9-alpha-fluoroprednisolone
16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol
16.alpha.-Methyl-9.alpha.-fluoroprednisolone
16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol
16alpha -Methyl-9alpha -fluoroprednisolone
16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol
16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone
16alpha-Methyl-9alpha-fluoroprednisolone
16α-Methyl-9α-fluoro-1-dehydrocortisol
23495-06-9
31375_FLUKA
46165_FLUKA
46165_RIEDEL
50-02-2
8054-59-9
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione
9-Fluoro-16-methylprednisolone
9-alpha-Fluoro-16-alpha-methylprednisolone
9.alpha.-Fluoro-16.alpha.-methylprednisolone
906422-84-2
9A-FLUORO-16BETA-METHYLPREDNISOLONE
9alpha -Fluoro-16alpha -methylprednisolone
9alpha-Fluoro-16alpha-methylprednisolone
9alpha-fluoro-16alpha-methyl-Prednisolone
9α-Fluoro-16α-methylprednisolone
AC-11056
AC1L1L1H
AC1Q29DM
AI3-50934
Adexone
Aeroseb-D
Aeroseb-Dex
Aeroseb-dex
Ak Dex Oph Otic Soln 0.1%
Alcon Brand of Dexamethasone
Anaflogistico
Aphtasolon
Aphthasolone
Apo-dexamethasone
Auxiron
Azimycin (veterinary)
Azium
Azium (Veterinary)
Azium (veterinary)
BIDD:ER0494
BIDD:PXR0060
BRD-K38775274-001-02-3
BRD-K38775274-001-06-4
BSPBio_000995
Baycadron
Bisu DS
Bisu Ds
C15643
C22H29FO5
CCRIS 7067
CHEBI:41879
CHEMBL384467
CID5743
CPD-10549
CPD001227192
Calonat
Corson
Corsone
Cortisumman
D00292
D003907
D1756_SIGMA
D4902_SIGMA
D6645_SIGMA
D8893_SIGMA
D9184_SIGMA
DB01234
DEX
DEXA
DEXONE 0.5
DEXONE 0.75
DEXONE 1.5
DEXONE 4
DXM
DXMS
Decacort
Decacortin
Decaderm
Decadron
Decadron (TN)
Decadron Tablets, Elixir
Decadron, Dexamethasone
Decadron-LA
Decadron-La
Decagel
Decaject
Decaject L.A.
Decaject-L.A.
Decalix
Decameth
Decasone
Decaspray
Dectancyl
Dekacort
Delta1-9alpha-Fluoro-16alpha-methylcortisol
Deltafluorene
Dergramin
Deronil
Desadrene
Desametasone
Desametasone [DCIT]
Desametasone [Dcit]
Desamethasone
Desameton
Deseronil
Dex-Ide
Dex-ide
Dexa
Dexa Mamallet
Dexa mamallet
Dexa-Cortidelt
Dexa-Cortisyl
Dexa-Mamallet
Dexa-Scheroson
Dexa-Sine
Dexa-cortidelt
Dexa-cortisyl
Dexa-scheroson
Dexa-sine
Dexacen-4
Dexacidin
Dexacort
Dexacortal
Dexacortin
Dexadeltone
Dexafarma
Dexair
Dexalona
Dexaltin
Dexametasona
Dexametasona [INN-Spanish]
Dexametasone
Dexameth
Dexamethansone
 
Dexamethasone
Dexamethasone (JP15/USP/INN)
Dexamethasone Acetate
Dexamethasone Alcohol
Dexamethasone Base
Dexamethasone Intensol
Dexamethasone Sodium Phosphate
Dexamethasone [INN:BAN:JAN]
Dexamethasone acetate
Dexamethasone alcohol
Dexamethasone base
Dexamethasone intensol
Dexamethasone sodium phosphate
Dexamethasone-omega
Dexamethasonum
Dexamethasonum [INN-Latin]
Dexamethazone
Dexamethsone
Dexamonozon
Dexapolcort
Dexapos
Dexaprol
Dexason
Dexasone
Dexasone 0.5mg
Dexasone 0.75mg
Dexasone 4mg
Dexasporin
Dexinolon
Dexinoral
Dexone
Dexone 0.5
Dexone 0.75
Dexone 1.5
Dexone 4
Dexonium
Dexpak
Dextelan
Dezone
Dinormon
Dxms
ECR Brand of Dexamethasone
EINECS 200-003-9
FT-0080377
Fluormethylprednisolone
Fluormone
Fluorocort
Fortecortin
Foy Brand of Dexamethasone
Gammacorten
HL-dex
HMS1792A17
HMS1990A17
HMS2089N13
HSDB 3053
Hexadecadrol
Hexadrol
Hexadrol Elixir
Hexadrol Tablets
Hexadrol elixir
Hl-Dex
Hl-dex
I06-1196
ICN Brand of Dexamethasone
IontoDex
Isopto-Dex
Isopto-dex
LS-7300
Lokalison F
Lokalison f
Loverine
Luxazone
MK 125
MLS001055412
MLS001332507
MLS001332508
Maxidex
Maxidex Ont 0.1%
Maxidex Sus 0.1%
Maxitrol
Mediamethasone
Merck Brand of Dexamethasone
Merz Brand 1 of Dexamethasone
Merz Brand 2 of Dexamethasone
Methylfluorprednisolone
Mexidex
Millicorten
MolMap_000018
MolPort-003-846-433
Mymethasone
NCGC00091019-01
NCGC00091019-02
NCGC00091019-03
NCGC00091019-04
NCGC00091019-05
NCI60_003067
NSC 34521
NSC34521
Naquasone (veterinary)
Neomycin and polymyxin b sulfates and dexamethasone
Neomycin and polymyxin b sulphates and dexamethasone
OTO-104
Ocu-Trol
Ocu-trol
Oradexon
Ozurdex
PHL-dexamethasone
PMS-dexamethasone
Pet Derm III
Pet Derm Iii
Pet derm III
Pet-Derm Iii
Pms Dexamethasone Elixir 0.5mg/5ml
Policort
Posurdex
Prednisolon F
Prednisolon f
Prednisolone F
Prednisolone f
Prodex
S1322_Selleck
SAM002548948
SGCUT00126
SK-Dexamethasone
SK-dexamethasone
SMP1_000092
SMR000857119
SMR001227192
ST50307091
Sandoz dexamethasone
Sk-Dexamethasone
Spectrum5_002019
Spoloven
Sunia Sol D
Sunia sol D
Superprednol
TL8003317
Tobradex
Tobramycin and dexamethasone
Tresaderm (veterinary)
Turbinaire
UNII-7S5I7G3JQL
Visumetazone
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ G1
ZINC03875332
alpha -Fluoro-16-alpha -methylcortisol
delta(Sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol
delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol
delta1-9alpha-Fluoro-16alpha-methylcortisol
dexamethasone
nchembio809-comp2
to_000038
2lenograstimPhase 11134
3Adjuvants, ImmunologicPhase 11783
4Immunologic FactorsPhase 118483
5Dexamethasone acetatePhase 119091177-87-3
6BB 1101Phase 11909
7Dexamethasone 21-phosphatePhase 11909
8
Tipranavirapproved, investigational74174484-41-465027
Synonyms:
174484-41-4
1d4y
2o4l
2o4n
2o4p
AC1L22FH
AC1Q4JPW
Aptivus
Aptivus (Boehringer Ingelheim)
Aptivus (TN)
Aptivus(TM)
CHEMBL222559
CID65027
 
D08605
DB00932
MolPort-003-850-561
N-(3-{(1R)-1-[(6R)-4-HYDROXY-2-OXO-6-PHENETHYL-6-PROPYL-5,6-DIHYDRO-2H-PYRAN-3-YL]PROPYL}PHENYL)-5-(TRIFLUOROMETHYL)-2-PYRIDINESULFONAMIDE
N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-phenethyl-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide
PNU 140690
PNU-140690
PNU-140690E
TPV
Tipranavir
Tipranavir (INN)
U 140690
U-140690
UNII-ZZT404XD09
tipranavir
9
Ritonavirapproved, investigational850155213-67-5392622
Synonyms:
1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
155213-67-5
1hxw
1sh9
5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S)-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate
5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate
538, ABT
A-84538
ABBOTT-84538
ABT 538
ABT 84538
ABT-538
ABT538
AC-733
AC1L94GB
AKOS000280930
Abbott 84538
BIDD:GT0387
BIDD:PXR0023
Bio-0093
C07240
C37H48N6O5S2
CHEBI:45409
CHEMBL163
CID392622
CPD000466395
D00427
D019438
 
DB00503
DRG-0244
FT-0082824
HMS2051B08
HSDB 7160
LS-148860
MLS000759541
MLS001424063
MolPort-000-883-877
N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide
NCGC00159462-02
NSC693184
Norvir
Norvir (TM)
Norvir (TN)
Norvir Sec
RIT
RTV
Ritonavir
Ritonavir (JAN/USAN/INN)
Ritonavir [USAN]
Ritonavir is an inhibitor of HIV protease used to treat HIV infection and AIDS.
Ritonavirum
S1185_Selleck
SAM001246783
SMR000466395
STK634209
ZINC03944422
ritonavir
10Antibodies4477
11Autoantibodies117
12Immunoglobulins4477
13Antiviral Agents8071
14Anti-Retroviral Agents2794
15Anti-Infective Agents17220

Interventional clinical trials:

idNameStatusNCT IDPhase
1A Twelve Week, Open Label Extension Study in Patients With SchizophreniaCompletedNCT01566162Phase 3
2PEARL Schizophrenia MaintenanceCompletedNCT01435928Phase 3
3An Integrated Program for the Treatment of First Episode of PsychosisActive, not recruitingNCT01321177Phase 2, Phase 3
4Improved Methods of Cell Selection for Bone Marrow Transplant AlternativesRecruitingNCT00001529Phase 1
5Literacy-Adapted Psychosocial Treatments for Chronic Pain --- "Learning About Mastering/My Pain"Active, not recruitingNCT01967342
6Serum Auto-AntibodiesActive, not recruitingNCT00704626
7Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV InfectionNo longer availableNCT00062660

Search NIH Clinical Center for Sick Building Syndrome


Cochrane evidence based reviews: sick building syndrome

Genetic Tests for Sick Building Syndrome

About this section

Anatomical Context for Sick Building Syndrome

About this section

MalaCards organs/tissues related to Sick Building Syndrome:

33
Testes, Eye, Bone, Endothelial, Prostate, Bone marrow, Lung

Animal Models for Sick Building Syndrome or affiliated genes

About this section

MGI Mouse Phenotypes related to Sick Building Syndrome:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00020068.5LEP, MMP9, POMC, TRPV1
2MP:00053678.2LEP, MMP9, POMC, TRPV1
3MP:00107718.1LEP, MMP9, PNPLA6, POMC, TRPV1
4MP:00053857.9LEP, MMP9, PNPLA6, POMC, TRPV1
5MP:00053867.4ITM2B, LEP, MMP9, PNPLA6, POMC, TRPV1
6MP:00036317.3ITM2B, LEP, MMP9, PNPLA6, POMC, TRPV1

Publications for Sick Building Syndrome

About this section

Articles related to Sick Building Syndrome:

(show top 50)    (show all 206)
idTitleAuthorsYear
1
Cognitive therapy in sick building syndrome: Myths, believes or evidence. (26654822)
2016
2
Endotoxin, ergosterol, muramic acid and fungal DNA in dust from schools in Johor Bahru, Malaysia--Associations with rhinitis and sick building syndrome (SBS) in junior high school students. (26745297)
2016
3
A Longitudinal Study of Sick Building Syndrome (SBS) among Pupils in Relation to SO2, NO2, O3 and PM10 in Schools in China. (25398002)
2014
4
Prevalence and risk factors of sick building syndrome among office workers. (23963091)
2013
5
Sick building syndrome by indoor air pollution in Dalian, China. (23579877)
2013
6
A longitudinal study of aldehydes and volatile organic compounds associated with subjective symptoms related to sick building syndrome in new dwellings in Japan. (22265600)
2012
7
The prevalence and incidence of sick building syndrome in Chinese pupils in relation to the school environment: a two-year follow-up study. (21615503)
2011
8
Sick building syndrome in a general hospital and the risks for pregnant workers. (21458809)
2011
9
The possible role of fungal contamination in sick building syndrome. (21196335)
2011
10
Association study between sick building syndrome and polymorphisms of seven human detoxification genes in the Japanese. (21787601)
2010
11
A longitudinal study of environmental risk factors for subjective symptoms associated with sick building syndrome in new dwellings. (19608217)
2009
12
An update on sick building syndrome. (19532093)
2009
13
Case study of volatile organic compounds in indoor air of a house before and after repair where sick building syndrome occurred. (17903361)
2007
14
Projective drawings for assessing stress among subjects with medical symptoms compatible with sick building syndrome, and validation of a modified version of the Stress Load Index from the Drawing Personality Profile: a pilot study. (17450971)
2007
15
Office work exposures [corrected] and respiratory and sick building syndrome symptoms. (17339295)
2007
16
Serum levels of volatile organic compounds in patients with sick building syndrome. (17033858)
2006
17
Associations among sick building syndrome, psychosocial factors, and personality traits. (16060437)
2005
18
Bioaerosols and sick building syndrome: particles, inflammation, and allergy. (15764903)
2005
19
A time-series study of sick building syndrome: chronic, biotoxin-associated illness from exposure to water-damaged buildings. (15681119)
2005
20
Multiple logistic regression modelling substantiates multifactor contributions associated with sick building syndrome in residential interiors in Mauritius. (12745349)
2003
21
The full circle: from the Minamata disaster to the sick building syndrome. (11564629)
2001
22
Why do women suffer from sick building syndrome more often than men?--subjective higher sensitivity versus objective causes. (11761596)
2001
23
The effects of outdoor air supply rate in an office on perceived air quality, sick building syndrome (SBS) symptoms and productivity. (11089327)
2000
24
Sick building syndrome. Indoor air quality and your patients' health. (11521615)
2000
25
The sick building syndrome. (10598396)
1999
26
Sick building syndrome. (10212636)
1999
27
The sick building syndrome as a subjective perception-theoretical approach and assessment methods. (10507132)
1999
28
Visual analogue scales for detecting changes in symptoms of the sick building syndrome in an intervention study. (10505662)
1999
29
Sick building syndrome: association of symptoms with serum IgE specific to fungi. (9561392)
1998
30
Sick-building syndrome. (9235451)
1997
31
Sick building syndrome, work factors and occupational stress. (8881012)
1996
32
Fungal colonization of fiberglass insulation in the air distribution system of a multi-story office building: VOC production and possible relationship to a sick building syndrome. (8757941)
1996
33
Sick building syndrome and gender bias: imperiling women's health. (7747241)
1995
34
The Sick Building Syndrome (SBS) in office workers. A case-referent study of personal, psychosocial and building-related risk indicators. (7721522)
1994
35
Building and Home-Related Complaints and Illnesses: Sick Building Syndrome. Conference proceedings. Lake Buena Vista, Florida, December 3-5, 1992. (7915735)
1994
36
Textile wall materials and sick building syndrome. (8185388)
1994
37
Town planning & health. Sick building syndrome. (10135739)
1994
38
Building components contributors of the sick building syndrome. (8175632)
1994
39
The effect of varying levels of outdoor-air supply on the symptoms of sick building syndrome. (8441426)
1993
40
Building-related illnesses and sick building syndrome. (8089648)
1993
41
Sick building syndrome--know your ventilation rates. (10126689)
1993
42
The feasibility of using a double blind experimental cross-over design to study interventions for sick building syndrome. (1607899)
1992
43
The sick building syndrome. (1580467)
1992
44
Field studies on the sick building syndrome. (1580471)
1992
45
High prevalence of sick building syndrome in a new air-conditioned building in Italy. (1539998)
1992
46
Sick building syndrome. (1683923)
1991
47
Environmental, occupational, and personal factors related to the prevalence of sick building syndrome in the general population. (1854648)
1991
48
The sick building syndrome: where is the epidemiologic basis? (2400024)
1990
49
Sick building syndrome. (2616483)
1989
50
The sick building syndrome. (3917804)
1985

Variations for Sick Building Syndrome

About this section

Expression for genes affiliated with Sick Building Syndrome

About this section
Search GEO for disease gene expression data for Sick Building Syndrome.

Pathways for genes affiliated with Sick Building Syndrome

About this section

Pathways related to Sick Building Syndrome according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.5LEP, POMC
2
Show member pathways
9.5LEP, POMC

GO Terms for genes affiliated with Sick Building Syndrome

About this section

Biological processes related to Sick Building Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1lipid metabolic processGO:00066299.6LEP, PNPLA6

Sources for Sick Building Syndrome

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet